Dr. Asante holds a BSc. in Medical Sciences, MD degree, Masters in Public Health from University of Ghana; and a PhD in infectious disease epidemiology from the London School of Hygiene and Tropical Medicine, UK. Dr. Asante also hold several certificates of public health advocacy, advanced epidemiology, medical ethics and good clinical practices.
Dr. Asante provided primary health care in rural Ghana after his internship at Korle-Bu Teaching Hospital in Ghana. He has interest in epidemiology of childhood illnesses particularly malaria and respiratory infections, health programme evaluation and access to health care.
Dr. Asante has served on several international and local public health committees. He is currently the Chair of an expert oversight committee to evaluate the impact of clinical trials in Africa (eICT Study) and a Co-chair of the Clinical Trial Partnership for RTSS malaria clinical trials in Africa.
Dr. Asante was the Head of Malaria Research for 8 years at the Kintampo Health Research Centre (KHRC) and currently the Head of Research and a management committee member at KHRC.
Dr. Asante is a visiting lecturer at the School of Public Health in Ghana and the Columbia University Mailman School of Public Health in the U. S. A. and has supervised several student thesis.
Dr. Asante has papers in peer review journals and has authored a book chapter.
Co-Principal Investigator: A Phase two multi-centre trials of GSK’s RTSS,S vaccine involving 440 children, March 2006 – June 2008.
Principal Investigator: Compliance to artesunate-amodiaquine, a pragmatic study Oct. 2005 – Oct. 2006. This study sought to assess patient’s compliance to artesuante amodiaquine to guide policy in educational messages to ensure compliance and prevent drug resistance.
Principal Investigator: Knowledge, attitudes, perceptions and reactions to artesunate-amodiaquine 2005 – Nov. 2006. The aim of this study was to explore the communities knowledge, attitudes and perceptions to the new antimalarial drug artesuante –amodiaquine. This study was essential in light of the public’s outcry with the introduction of artesuante amodiaquine for the treatment of uncomplicated malaria.
Principal Investigator: Baseline Health Survey in the Asutifi, Tano N/S districts using techiman as a control area. The aim of this study was to determine baseline health indices that would be used in monitoring and evaluating public health interventions in a mining area.
Co-Investigator: Prevalence of G6PD diffeciency among pregnant women in Ghana and reactions to Sulphurdoxine-Pyrimethamine (SP). The aim of this study was to determine the prevalence of G6PD deficiency among pregnant women and the burden of reactions when they routinely receive SP at the antenatal clinics.
Project Coordinator –MeVISS project (July 2004 – Nov. 2005): There was a fatal outbreak of W135 strain of N. meningococci in 2002 in Burkina Faso. This study evaluated the immunogenicity and safety of a cheaper GSK Nm ACW135 polysaccharide vaccine with an expensive Nm ACYW135 polysaccharide vaccine. This study is in collaboration with the Navrongo Health Research Center, Ghana Health Service and the London School of Hygiene and Tropical Medicine.
Co-Investigator, Gates Malaria Partnership Project 1 (October 2003 - November 2004) : The general objective of this study was to determine baseline indices of malaria in the Kintampo district as a site for future malaria drug and vaccine studies. This study is in collaboration with the Noguchi Medical Research Institute, University of Ghana, Ghana and the London School of Hygiene and Tropical Medicine.
Co-Investigator, Gates Malaria Partnership Project 2: The main aim of this study was to evaluate the efficacy of artemisinin combination drugs for treating uncomplicated falciparum malaria in the study area. The profiles of these drugs will help in choosing an efficacious drug for intermittent preventive treatment in infant/children.
Co-Investigator –Sprinkles project (March 2002 – 2006): The Sprinkles projects were a series of studies that sought to determine the efficacy, acceptability, and effectiveness of sprinkles (powdered microencapsulated iron) to address the burden of nutritional anemia. These have been in collaboration with the Hospital for Sick-kids, Canada. Policy implications are being considered.
Project Clinician –EPI ++ study (September 2002 – October 2004): The objective of this study was to evaluate the WHO newly proposed mode of supplementation of young infants and their mothers with Vitamin A.
Dr. Asante is a member of the following professional associations:
Member, Ghana Medical Association
Member, Association of Clinical Research Professionals, East African Chapter
Member, Newmont Gold Mining Committee on Community Health & Social Welfare Committee.
Book/ Newsletter Contributions